Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Metadherin (MTDH) is implicated in various human malignancies.
• The role of MTDH in diffuse large-B-cell lymphoma (DLBCL) remains unexplored.

Purpose of the Study:

• To investigate the expression and function of MTDH in the pathogenesis of DLBCL.
• To elucidate the molecular mechanisms underlying MTDH's role in DLBCL.

Main Methods:

• Quantitative PCR and Western-blot analysis to assess MTDH mRNA and protein levels in DLBCL tissues and cell lines.
• Immunohistochemical analysis to correlate MTDH expression with clinical staging.
• RNA interference (siRNA) to inhibit MTDH expression and assess its impact on cell apoptosis.
• Analysis of Wnt/β-catenin signaling pathway components.

Main Results:

• MTDH mRNA and protein expression were significantly elevated in DLBCL tissues and cell lines compared to controls.
• High MTDH expression (76.67%) correlated with advanced clinical staging in DLBCL patients.
• MTDH overexpression enhanced DLBCL cell proliferation and inhibited apoptosis, while MTDH knockdown induced apoptosis.
• MTDH upregulation increased total and nuclear β-catenin levels, indicating Wnt/β-catenin pathway activation.

Conclusions:

• MTDH plays a significant role in DLBCL pathogenesis through the activation of the Wnt/β-catenin signaling pathway.
• MTDH may serve as a potential diagnostic biomarker and therapeutic target for DLBCL.